Xenon Pharmaceuticals - 53 Year Dividend History | XENE
Historical dividend payout and yield for Xenon Pharmaceuticals (XENE) since 1971. The current TTM dividend payout for Xenon Pharmaceuticals (XENE) as of December 20, 2024 is $0.00. The current dividend yield for Xenon Pharmaceuticals as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.966B |
$0.009B |
|
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
